Jove
Visualize
お問い合わせ

関連する概念動画

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

238
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
238
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

204
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
204
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

442
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
442
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

345
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
345
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.5K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.5K
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー
  1. ホーム
  2. 結核性髄膜炎に関する臨床ガイドライン
  1. ホーム
  2. 結核性髄膜炎に関する臨床ガイドライン

関連する実験動画

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
06:23

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

Published on: May 23, 2021

4.9K

結核性髄膜炎に関する臨床ガイドライン

Joseph Donovan1, Fiona V Cresswell2, Elizabeth W Tucker3

  • 1Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.

The Lancet. Infectious diseases
|August 21, 2025

PubMed で要約を見る

まとめ
この要約は機械生成です。

結核性髄膜炎の管理には現在の国際的指針がない. この体系的なレビューは,証拠に基づいた勧告を提供し,この重度の結核に対する重要な研究ギャップを特定しています.

さらに関連する動画

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.3K
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

348

関連する実験動画

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
06:23

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

Published on: May 23, 2021

4.9K
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.3K
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

348

科学分野:

  • 感染症
  • 神経学
  • 公衆衛生

背景:

  • 結核性髄膜炎は重度の結核であり,死亡率や障害率が高い.
  • 結核性髄膜炎の管理に関する現在の国際的ガイドラインは時代遅れです.
  • 最適な診断と治療戦略が 緊急に必要とされています

研究 の 目的:

  • 結核性髄膜炎の管理に関する証拠を体系的に検討する.
  • 診断,化学療法,サポートケアのための実践ガイドを開発する.
  • 将来の研究のための知識と証拠のギャップを特定する.

主な方法:

  • 集団,介入,比較,結果 (PICO) 形式による体系的なレビュー
  • 推薦,評価,開発,評価の格付け (GRADE) は,エビデンスの質に関するアプローチです.
  • 国際的なコンソーシアム代表の参加

主要な成果:

  • 結核性髄膜炎の診断と治療に関する根拠に基づいた勧告
  • 専門家の意見が実践指針に組み込まれている.
  • 重要な知識と証拠のギャップを特定する.

結論:

  • 結核性髄膜炎の国際ガイドラインの更新が不可欠です
  • 体系的なレビューは,最適な患者のケアのための基盤を提供します.
  • 将来の研究優先事項は,現在の証拠不足に対処するために強調されています.